Page last updated: 2024-08-23

nicorandil and Elevated Cholesterol

nicorandil has been researched along with Elevated Cholesterol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Genda, S; Ichikawa, Y; Miki, T; Miura, T; Shimamoto, K1
Ambrosi, P; Andréjak, M; Gayet, JL1

Reviews

1 review(s) available for nicorandil and Elevated Cholesterol

ArticleYear
[The best of clinical pharmacology in 2002].
    Archives des maladies du coeur et des vaisseaux, 2003, Volume: 96 Spec No 1

    Topics: Anticholesteremic Agents; Antihypertensive Agents; Azetidines; Cardiovascular Diseases; Ezetimibe; Hormone Replacement Therapy; Humans; Hydrazones; Hypercholesterolemia; Losartan; Myocardial Infarction; Natriuretic Agents; Natriuretic Peptide, Brain; Neovascularization, Physiologic; Nicorandil; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents

2003

Other Studies

1 other study(ies) available for nicorandil and Elevated Cholesterol

ArticleYear
K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia.
    Journal of the American College of Cardiology, 2002, Oct-02, Volume: 40, Issue:7

    Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Chronic Disease; Coronary Circulation; Disease Models, Animal; Glyburide; Hemodynamics; Hypercholesterolemia; Male; Myocardial Infarction; Nicorandil; Nitric Oxide Synthase; omega-N-Methylarginine; Potassium Channel Blockers; Potassium Channels; Rabbits; Vasodilator Agents

2002